Suven Life Sciences Balance Sheet Health
Financial Health criteria checks 6/6
Suven Life Sciences has a total shareholder equity of ₹2.7B and total debt of ₹7.1M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are ₹2.8B and ₹148.6M respectively.
Key information
0.3%
Debt to equity ratio
₹7.10m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹2.40b |
| Equity | ₹2.70b |
| Total liabilities | ₹148.62m |
| Total assets | ₹2.85b |
Recent financial health updates
Suven Life Sciences (NSE:SUVEN) Is In A Good Position To Deliver On Growth Plans
Oct 26
Companies Like Suven Life Sciences (NSE:SUVEN) Are In A Position To Invest In Growth
Jun 21Recent updates
Financial Position Analysis
Short Term Liabilities: SUVEN's short term assets (₹2.6B) exceed its short term liabilities (₹135.2M).
Long Term Liabilities: SUVEN's short term assets (₹2.6B) exceed its long term liabilities (₹13.5M).
Debt to Equity History and Analysis
Debt Level: SUVEN has more cash than its total debt.
Reducing Debt: SUVEN's debt to equity ratio has reduced from 4.6% to 0.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SUVEN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SUVEN has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 7.7% each year.